Skip to content
Ireland

Peptide ads in Ireland: HPRA rules and an Irish launch checklist

Build an Irish peptide advertising brief with HPRA medicine checks, clear product claims, Republic of Ireland targeting and a practical Meta launch checklist.

Dublin-inspired Georgian doors with a glass leaf and molecular sculpture
Adnoxx Editorial TeamPublished 5 min read

An English campaign can cross a border without looking different. Its obligations can still change. If your peptide brand is moving from the UK into Ireland, copying the ad and widening the location setting is an incomplete launch plan.

Start with the Republic of Ireland as a distinct market. Check the product, the public advertising rules, the audience and the fulfillment route. For an eligible offer, the strongest first campaign often answers ordinary buyer questions clearly rather than making a more aggressive peptide claim.

In this guide
  1. Read the HPRA rules before the creative brief
  2. Keep Ireland and Northern Ireland explicit
  3. Make the intended buyer visible in the message
  4. Treat Meta acceptance as a separate gate
  5. Use a small launch to find commercial friction
  6. Answer the launch team's last questions

Read the HPRA rules before the creative brief

The Health Products Regulatory Authority states that prescription-only medicines cannot be promoted to the public in Ireland. Its current social-media guidance covers businesses and individuals, including services involving medicines. The format of the post does not make the underlying product promotion disappear. HPRA: promoting medicines to the public on social media.

This matters when a store mixes cosmetics, research compounds and treatment-oriented messaging. Write down what the advertised item actually is. Record the formulation, presentation, intended use and buyer. A category should come from a defensible product assessment, not from the label that seems most convenient for advertising.

If the offer is a medicine, use the HPRA's product information and advertising guidance to establish its status and applicable conditions. Do not assume that a product authorized elsewhere has the same Irish position. HPRA medicine advertising guidance.

Keep Ireland and Northern Ireland explicit

The Republic of Ireland and Northern Ireland are not interchangeable campaign labels. They involve different jurisdictions and may involve different sellers, delivery arrangements and product decisions. Define which market the campaign serves before choosing its audience and approving its destination.

A practical campaign name might identify the Republic of Ireland, the language and the product family. That is an internal organization choice, not a regulatory solution. The same clarity should appear in shipping coverage and support materials, so a buyer can understand whether the offer applies to their address.

Launch decisionRepublic of Ireland briefWhat to verify separately
ProductExact locally reviewed offerAny Northern Ireland or UK version
PriceApproved euro price and chargesCurrency and checkout for other markets
DeliveryActual dispatch route and coverageDifferent border or carrier arrangements
SupportContact route and response coverageWhether the advertised service is available

Avoid promoting an all-island delivery promise unless the operation can meet it and the offer is appropriate in both jurisdictions. If coverage differs, explain the difference before checkout. A precise promise is easier to keep and easier for the campaign team to assess.

Make the intended buyer visible in the message

A genuine laboratory supplier should explain the professional offer with suitable technical and ordering information. A consumer cosmetic should be presented as the finished cosmetic it is. Blending research terminology with personal treatment outcomes confuses both the intended use and the customer's expectations.

For an eligible product, test whether a new reader can answer three questions after seeing the ad: What is being sold? Who is it for? What happens after clicking? If the reader infers a medical outcome that the evidence does not support, revise the full message, including the image.

Keep creator briefs just as specific. Supply a factual description, permitted evidence and prohibited extrapolations. Review the final caption, voiceover and destination together. A creator's enthusiasm should not add a health promise that the brand would not make on its own product page.

Treat Meta acceptance as a separate gate

The Irish product assessment and the platform assessment answer different questions. Check the current Meta policy for drugs and pharmaceuticals for the exact offer and advertiser. Neither a functioning shop nor a competitor's active ad proves your eligibility.

Save the complete version submitted for review. That includes the visible product page and the material linked from it, not just the exported banner. If a campaign is rejected, gather the stated reason and assess it against the real offer. Do not respond by hiding the same restricted sale behind a different headline or sending it through a replacement account.

Use a small launch to find commercial friction

After the eligibility work, choose a limited set of distinct questions to test. Packaging clarity, ordering confidence and relevant product facts can support different concepts without escalating the claim. Keep the audience, page and offer stable enough to interpret the results.

Inspect the Irish checkout with a real delivery address format and the payment methods actually offered. Confirm the selected currency, order confirmation, shipping explanation and support link. Record the result of a normal test transaction through your established testing process; avoid using real sensitive customer information as a debugging sample.

Review successful orders alongside abandoned checkouts and support questions. A delivery concern may need a clearer page, while a mismatch about intended use may require a deeper product-message correction. Do not put every weak result into the same category of poor creative.

Answer the launch team's last questions

Can a UK medicine ad simply target Ireland too?

Do not assume so. Establish the Irish product and advertising position, then the platform position. The same English words can promote a differently regulated offer in another jurisdiction.

Does calling the audience professional solve eligibility?

A label or interest selection does not establish a genuine restricted professional audience. Assess the actual audience, access arrangements and rules for the offer. If public promotion is prohibited, a broad social campaign is not made acceptable by naming it B2B.

What should an eligible Irish campaign brief contain?

Use the product decision, exact claims, evidence links, Republic of Ireland coverage, final page, measurement boundary and accountable owner. These make the campaign review concrete and reduce avoidable handoffs.

Adnoxx brings eligible campaign creation and performance review into one dashboard. See account management once your Irish brief is ready. Official sources reviewed on 11 October 2026.

Your next step

A clearer way to run your next campaign.

Explore the platform, see the workflow and decide whether Adnoxx fits your brand.

Apply for access
Peptide ads in Ireland: HPRA rules and an Irish launch checklist · Adnoxx